The safety and efficacy of MenoTreatTM, a new balloon device for thermal endometrial ablation

Ulmsten, Ulf; Carstensen, Helena; Falconer, Christian; Holm, Leif; Lanner, Lars; Nilsson, Staffan; Rasmussen, Carsten; Redvall, Lars; Rådestad, Angelique Flöter; Simonsen, Benthe; Bergelin, Ingemar

doi:10.1034/j.1600-0412.2001.800110.x

Cited by 12 publications

(12 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Various endometrial ablation techniques have been developed and studied since the 1990s (7–11). Hysteroscopic endometrial resection using glycine as a distension medium has been used in Finland by Tapper and Heinonen with good clinical outcome (14,15); this procedure, however, requires experience in operative hysteroscopy by the gynecologist.…”

Section: Discussionmentioning

confidence: 99%

“…In Finland, most clinical experience regarding thermoablation has been obtained using the Cavaterm ® ablation system (Wallsten Medical SA, Moryes, Switzerland) (10) and, more recently, using the MenoTreat ® (Atos Medical AB, Hörby, Sweden) method (11). In the present paper, we describe the comparison of these methods in a randomized setting in 31 patients referred to hospital because of menorrhagia.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Endometrial thermoablation for treatment of menorrhagia: comparison of two methods in outpatient setting

Vihko

Raitala

Taina

2003

Acta Obstet Gynecol Scand

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

Endometrial thermoablation for treatment of menorrhagia: comparison of two methods in outpatient setting

Vihko

Raitala

Taina

2003

Acta Obstet Gynecol Scand

View full text Add to dashboard Cite

show abstract

“…As it has been newly developed and first presented in 1999, clinical experience is limited. Success rates in terms of 50% reduction of menstrual bleeding in approximately 84% of patients at 6 months after treatment have been reported (152). The VestaBlate TM (Vesta Medical, Mountain View, CA, USA) is a new multielectrode balloon.…”

Section: Methodsmentioning

confidence: 99%

Menorrhagia: an update

Oehler

Rees

2003

Acta Obstet Gynecol Scand

140

View full text Add to dashboard Cite

Menorrhagia is defined as a 'complaint of heavy cyclical menstrual bleeding occurring over several consecutive cycles'. Objectively it is a total menstrual blood loss equal to or greater than 80 ml per menstruation. It is estimated that approximately 30% of women complain of menorrhagia. Excessive bleeding is the main presenting complaint in women referred to gynecologists and it accounts for two-thirds of all hysterectomies, and most of endoscopic endometrial destructive surgery. Thus, menorrhagia is an important healthcare problem. Its etiology, investigation, medical and surgical management are described. In approximately 50% of cases of menorrhagia no pathology is found at hysterectomy. Abnormal levels of prostaglandins or the fibrinolytic system in the endometrium have been implicated. Effective medical treatments suitable for long-term use include intrauterine progestogens, antifibrinolytic agents (tranexamic acid) and nonsteroidal anti-inflammatory agents (mefenamic acid). Over the past decade there has been increasing use of endometrial destructive techniques as an alternative to hysterectomy. Their further refinement and the advent of fibroid embolization has increased the options available to women.

show abstract

“…There are very few studies on this device in the literature. In a Swedish study, 33 51 women underwent treatment. At the 6‐month follow‐up the treatment was successful in 84.3% of women; amenorrhoea occurred in 10% of women treated.…”

Section: Second‐generation Devicesmentioning

confidence: 99%

Current minimal access techniques in the treatment of heavy menstrual bleeding

Justin

Ibraheim

Bagtharia

et al. 2007

The Obstetric & Gynaecologis

View full text Add to dashboard Cite

Key content Heavy menstrual bleeding remains a major problem for some women. Hysterectomy is the leading treatment for this condition but it is recognised to have some serious complications. First‐generation endometrial ablation techniques have a steep learning curve and are carried out under hysteroscopic visualisation. Second‐generation techniques are simpler and have lower complication rates, lower analgesia requirements and potential for outpatient use. Individual assessment is important in deciding the route and method of treatment for heavy menstrual bleeding, taking clinical factors into consideration. Learning objectives To know about the various options currently available for endometrial ablation. To learn about the clinical application, advantages and limitations of various methods of endometrial ablation. To be able to make an informed choice when deciding which modality to use. Ethical issues Intense competition will continue to drive device manufacturers to make claims of effectiveness based on poor‐quality evidence. All users have a responsibility to be well informed and to offer evidence‐based advice to women. Please cite this article as: Justin W, Ibraheim M, Bagtharia S, Haloob R. Current minimal access techniques in the treatment of heavy menstrual bleeding. The Obstetrician & Gynaecologist 2007;9:223–232.

show abstract

The safety and efficacy of MenoTreatTM, a new balloon device for thermal endometrial ablation

Cited by 12 publications

References 29 publications

Endometrial thermoablation for treatment of menorrhagia: comparison of two methods in outpatient setting

Endometrial thermoablation for treatment of menorrhagia: comparison of two methods in outpatient setting

Menorrhagia: an update

Current minimal access techniques in the treatment of heavy menstrual bleeding

Contact Info

Product

Resources

About